mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
0.0008 |
mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0009 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.001 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.001 |
mRNA |
paclitaxel |
FIMM |
pan-cancer |
AAC |
-0.52 |
0.001 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.002 |
mRNA |
Y-39983 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.002 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.19 |
0.002 |